"Maybe they could answer the question, is the 95th biosimilar switching trial likely to show something different to the previous 94?" asks UK oncologist Dr Paul Cornes. …
Latest Video
New Stories
-
Department to pay for Labor's Health Reform Commission
February 15, 2019 - - Latest News -
Department confirms 52 PBAC recommendations still unfunded
February 15, 2019 - - Latest News -
Is this an evidence-based system?
February 15, 2019 - - Latest News -
PHARMAC responds to criticism by announcing it will review itself
February 15, 2019 - - Latest News -
Offer a reduction and we will be more 'receptive'
February 14, 2019 - - Latest News -
Strong result for CSL
February 14, 2019 - - Latest News -
A relationship that just 'masks' a difficult reality
February 14, 2019 - - Comment